These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6885899)

  • 1. Stimulating effect of ascorbic acid on ascites tumor cell multiplication in vitro.
    Liotti FS; Bodo M; Talesa V
    J Cancer Res Clin Oncol; 1983; 106(1):69-70. PubMed ID: 6885899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ascorbic and dehydroascorbic acid on the multiplication of tumor ascites cells in vitro.
    Liotti FS; Menghini AR; Guerrieri P; Talesa V; Bodo M
    J Cancer Res Clin Oncol; 1984; 108(2):230-2. PubMed ID: 6470029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset and growth rate of solid tumours derived from implanted ascites tumour cells pretreated with ascorbic acid.
    Liotti FS; Locci P
    Boll Ist Sieroter Milan; 1986; 65(1):61-4. PubMed ID: 3718681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of accumulation phenomena in normal and tumoral tissues of mice treated with ascorbic acid.
    Liotti FS; Talesa V; Menghini AR
    Int J Vitam Nutr Res; 1983; 53(3):251-7. PubMed ID: 6629664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism between catalase and ascorbic acid in control of normal and neoplastic cell multiplication.
    Liotti FS; Bodo M; Menghini AR; Guerrieri P; Pezzetti F
    Cancer Lett; 1986 Oct; 33(1):99-106. PubMed ID: 3768864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs.
    Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M
    Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous tumor growth factor indicated by increased ornithine decarboxylase activity in malignant cells treated with host serum ascites fluid.
    Vaage J; Agarwal S
    Cancer Res; 1979 May; 39(5):1511-7. PubMed ID: 427794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals.
    Mashiba H; Matsunaga K
    Jpn J Exp Med; 1990 Aug; 60(4):209-14. PubMed ID: 2292808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
    Luo JC; Toyoda M; Shibuya M
    Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts.
    Tsao CS
    Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1274S-1280S. PubMed ID: 1962582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of leucocytes in ascites in the production of factor(s) stimulating differentiation of mouse myeloid leukemia cells.
    Hozumi M; Takenaga K; Tomida M; Okabe J
    Gan; 1977 Oct; 68(5):643-52. PubMed ID: 201536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
    Benedict WF; Wheatley WL; Jones PA
    Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites tumors in CBA mice. Characterization of two new tumors, a carcinoma and a sarcoma in solid and ascites form, with regard to cell surface properties and transplantability.
    Ryd W; Hagmar B
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):185-99. PubMed ID: 468905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Antitumor Activity of 2-O-α-d-Glucopyranosyl-6-O-(2-Pentylheptanoyl)-l-Ascorbic Acid.
    Miura K; Haraguchi M; Ito H; Tai A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of L-ascorbic acid on Ehrlich ascites carcinoma and Yoshida sarcoma in vitro and in vivo].
    KLINGER W; KLINGER H; KERSTEN L
    Acta Biol Med Ger; 1962; 8():53-9. PubMed ID: 14457029
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of VEGF and its receptors in ascites tumor formation.
    Shibuya M; Luo JC; Toyoda M; Yamaguchi S
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S72-7. PubMed ID: 10357563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells.
    Saeed RW; Peng T; Metz CN
    Exp Biol Med (Maywood); 2003 Jul; 228(7):855-65. PubMed ID: 12876306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for the radionuclide measurement of ascitic fluid volumes.
    Kaplan WD; Davis MA; Uren RF; Wisotsky T; LaTegola M
    J Nucl Med; 1978 Oct; 19(10):1138-41. PubMed ID: 722324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different behaviour of normal and neoplastic cells cultured in vitro in the presence of catalase and superoxide dismutase.
    Liotti FS; Bodo M; Menghini AR; Guerrieri P; Mariucci G; Bruschelli G
    Int J Cancer; 1987 Sep; 40(3):354-7. PubMed ID: 3040600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.